Secondary outcomes
uremia
REGRESSION, SECONDARY, VOLUME OVERLOAD, UREMIA
The results of the secondary outcomes are shown in Secondary outcomes, A) Survival, B) serum urea, and C) urinary output, during the 7 days of the study trial.A total of 17 (19%) patients required KRT during the study follow-up period, which was mostly due to uremia, volume overload, and electrolyte abnormalities; this included 12 (26%) in the probiotic group and 5 (12) in the placebo group, with an RR of 2.19 (95% CI 0.84–5.72, Additionally, urea levels (mg/dL) decreased significantly in the probiotic group from 154 (70–173) to 80 (31–148), which was not observed in the placebo group, in which they only decreased from 130 (70–173) to 109 (53–160), (Urinary volume (ml/day) increased from 1,000 (500–1,500) to 1,100 (750–1,400) in the intervention group (The patients were followed for a median of 382 days (193–967), and it was observed that their renal function deteriorated, which was based on an overall eGFR of 39 (23–94 mL/min/1.73 mIn an exploratory multiple regression analysis, including baseline sodium and potassium levels, heart rate, diastolic blood pressure and stages KDIGO 3 in the model and weighting by group, the results for renal recovery and mortality remained nonsignificant, with 